_id
6915eda5bc934aba376b1e2a
Ticker
REGMF
Name
RemeGen Co. Ltd
Exchange
PINK
Address
58 Middle Beijing Road, Yantai, China
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.remegen.com
Description
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of various cancers. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Last Close
9.81
Volume
-
Current Price
9.81
Change
0
Last Updated
2026-01-06T10:08:32.830Z
Image
-
Ipo Date
-
Market Cap
5528997376
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
86661056
Cost Of Revenue
13414065
Gross Profit
73246990
Operating Expenses
86352420
Operating Income
-13105429
Interest Expense
2137347
Pretax Income
-14194079
Net Income
-14194079
Eps
-0.025263382871981304
Dividends Per Share
-
Shares Outstanding
208581239
Income Tax Expense
-
EBITDA
-12129878
Operating Margin
-15.122627861816037
Total Other Income Expense Net
-1088650
Cash
150261200
Short Term Investments
15351228
Receivables
95596811
Inventories
92321278
Total Current Assets
381753144
Property Plant Equipment
408132264
Total Assets
839157128
Payables
27343436
Short Term Debt
205178373
Long Term Debt
-
Total Liabilities
513429851
Equity
325727276
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
64631793
Capital Expenditures
7881937
Cash From Investing
-22867345
Cash From Financing
-69955004
Net Change In Cash
-27469544
Cf_currency_symbol
-
PE
-
PB
16.921178004663016
ROE
-4.3576574778465895
ROA
-1.6914685612966633
FCF
56749856
Fcf Percent
0.6548484246487835
Piotroski FScore
2
Health Score
36
Deep Value Investing Score
3.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
3
Quality Investing Score
3.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
86661056
Quarters > 0 > income Statement > cost Of Revenue
13414065
Quarters > 0 > income Statement > gross Profit
73246990
Quarters > 0 > income Statement > operating Expenses
86352420
Quarters > 0 > income Statement > operating Income
-13105429
Quarters > 0 > income Statement > interest Expense
2137347
Quarters > 0 > income Statement > pretax Income
-14194079
Quarters > 0 > income Statement > net Income
-14194079
Quarters > 0 > income Statement > eps
-0.025263382871981304
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
561843957
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-12129878
Quarters > 0 > income Statement > operating Margin
-15.122627861816037
Quarters > 0 > income Statement > total Other Income Expense Net
-1088650
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
150261200
Quarters > 0 > balance Sheet > short Term Investments
15351228
Quarters > 0 > balance Sheet > receivables
95596811
Quarters > 0 > balance Sheet > inventories
92321278
Quarters > 0 > balance Sheet > total Current Assets
381753144
Quarters > 0 > balance Sheet > property Plant Equipment
408132264
Quarters > 0 > balance Sheet > total Assets
839157128
Quarters > 0 > balance Sheet > payables
27343436
Quarters > 0 > balance Sheet > short Term Debt
205178373
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
513429851
Quarters > 0 > balance Sheet > equity
325727276
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-14194079
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
64631793
Quarters > 0 > cash Flow > capital Expenditures
7881937
Quarters > 0 > cash Flow > cash From Investing
-22867345
Quarters > 0 > cash Flow > cash From Financing
-69955004
Quarters > 0 > cash Flow > net Change In Cash
-27469544
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.025263382871981304
Quarters > 0 > ratios > PB
16.921178004663016
Quarters > 0 > ratios > ROE
-4.3576574778465895
Quarters > 0 > ratios > ROA
-1.6914685612966633
Quarters > 0 > ratios > FCF
56749856
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.6548484246487835
Quarters > 0 > health Score
36
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
571984813
Quarters > 1 > income Statement > cost Of Revenue
86988325
Quarters > 1 > income Statement > gross Profit
484996488
Quarters > 1 > income Statement > operating Expenses
676404131
Quarters > 1 > income Statement > operating Income
-191407643
Quarters > 1 > income Statement > interest Expense
19564432
Quarters > 1 > income Statement > pretax Income
-195424193
Quarters > 1 > income Statement > net Income
-195424193
Quarters > 1 > income Statement > eps
-0.36816222664861453
Quarters > 1 > income Statement > dividends Per Share
-17864236
Quarters > 1 > income Statement > shares Outstanding
530810004
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-105332997
Quarters > 1 > income Statement > operating Margin
-33.46376313666216
Quarters > 1 > income Statement > total Other Income Expense Net
-4016550
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1283086269
Quarters > 1 > balance Sheet > short Term Investments
9171000
Quarters > 1 > balance Sheet > receivables
561591513
Quarters > 1 > balance Sheet > inventories
641247289
Quarters > 1 > balance Sheet > total Current Assets
2698160081
Quarters > 1 > balance Sheet > property Plant Equipment
2836929278
Quarters > 1 > balance Sheet > total Assets
5850358104
Quarters > 1 > balance Sheet > payables
209201828
Quarters > 1 > balance Sheet > short Term Debt
1828574744
Quarters > 1 > balance Sheet > long Term Debt
816730000
Quarters > 1 > balance Sheet > total Liabilities
3492867531
Quarters > 1 > balance Sheet > equity
2357490572
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
-195424193
Quarters > 1 > cash Flow > depreciation
160486384
Quarters > 1 > cash Flow > change In Working Capital
86918629
Quarters > 1 > cash Flow > cash From Operations
-57224123
Quarters > 1 > cash Flow > capital Expenditures
84913900
Quarters > 1 > cash Flow > cash From Investing
-92261936
Quarters > 1 > cash Flow > cash From Financing
703612099
Quarters > 1 > cash Flow > net Change In Cash
552217277
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.36816222664861453
Quarters > 1 > ratios > PB
2.2088088924242792
Quarters > 1 > ratios > ROE
-8.289500510460577
Quarters > 1 > ratios > ROA
-3.340380016505055
Quarters > 1 > ratios > FCF
-142138023
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.24849964504214905
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
525968624
Quarters > 2 > income Statement > cost Of Revenue
88030755
Quarters > 2 > income Statement > gross Profit
437937869
Quarters > 2 > income Statement > operating Expenses
687684366
Quarters > 2 > income Statement > operating Income
-249746497
Quarters > 2 > income Statement > interest Expense
19807444
Quarters > 2 > income Statement > pretax Income
-254144469
Quarters > 2 > income Statement > net Income
-254144469
Quarters > 2 > income Statement > eps
-0.4600000000723998
Quarters > 2 > income Statement > dividends Per Share
-23994702
Quarters > 2 > income Statement > shares Outstanding
552487976
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-169176484
Quarters > 2 > income Statement > operating Margin
-47.483155002797275
Quarters > 2 > income Statement > total Other Income Expense Net
-4397972
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
721718278
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
546450919
Quarters > 2 > balance Sheet > inventories
638250683
Quarters > 2 > balance Sheet > total Current Assets
2160787693
Quarters > 2 > balance Sheet > property Plant Equipment
2766884584
Quarters > 2 > balance Sheet > total Assets
5307345039
Quarters > 2 > balance Sheet > payables
183333479
Quarters > 2 > balance Sheet > short Term Debt
1631819108
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3535919947
Quarters > 2 > balance Sheet > equity
1771425097
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-254144469
Quarters > 2 > cash Flow > depreciation
57751767
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-188315134
Quarters > 2 > cash Flow > capital Expenditures
35638909
Quarters > 2 > cash Flow > cash From Investing
-26787884
Quarters > 2 > cash Flow > cash From Financing
176723966
Quarters > 2 > cash Flow > net Change In Cash
-40747050
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.4600000000723998
Quarters > 2 > ratios > PB
3.0596309455809862
Quarters > 2 > ratios > ROE
-14.346893325063917
Quarters > 2 > ratios > ROA
-4.788542428134377
Quarters > 2 > ratios > FCF
-223954043
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.4257935412512363
Quarters > 2 > health Score
20
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
507987407
Quarters > 3 > income Statement > cost Of Revenue
101973993
Quarters > 3 > income Statement > gross Profit
406013414
Quarters > 3 > income Statement > operating Expenses
805806983
Quarters > 3 > income Statement > operating Income
-399793569
Quarters > 3 > income Statement > interest Expense
16326733
Quarters > 3 > income Statement > pretax Income
-396934163
Quarters > 3 > income Statement > net Income
-396934163
Quarters > 3 > income Statement > eps
-0.7402334403578233
Quarters > 3 > income Statement > dividends Per Share
-16607781
Quarters > 3 > income Statement > shares Outstanding
536228359
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-328629127
Quarters > 3 > income Statement > operating Margin
-78.70147241661839
Quarters > 3 > income Statement > total Other Income Expense Net
2859406
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
759530000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
623535000
Quarters > 3 > balance Sheet > inventories
659369000
Quarters > 3 > balance Sheet > total Current Assets
2289798000
Quarters > 3 > balance Sheet > property Plant Equipment
2978506000
Quarters > 3 > balance Sheet > total Assets
5498519000
Quarters > 3 > balance Sheet > payables
162250000
Quarters > 3 > balance Sheet > short Term Debt
1432539000
Quarters > 3 > balance Sheet > long Term Debt
1195878000
Quarters > 3 > balance Sheet > total Liabilities
3512318000
Quarters > 3 > balance Sheet > equity
1986201000
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
-396934163
Quarters > 3 > cash Flow > depreciation
302728399
Quarters > 3 > cash Flow > change In Working Capital
-260942025
Quarters > 3 > cash Flow > cash From Operations
-279200450
Quarters > 3 > cash Flow > capital Expenditures
85330221
Quarters > 3 > cash Flow > cash From Investing
177571386
Quarters > 3 > cash Flow > cash From Financing
190910359
Quarters > 3 > cash Flow > net Change In Cash
97523820
Quarters > 3 > cash Flow > currency_symbol
CNY
Quarters > 3 > ratios > PE
-0.7402334403578233
Quarters > 3 > ratios > PB
2.648473242028375
Quarters > 3 > ratios > ROE
-19.984591841409806
Quarters > 3 > ratios > ROA
-7.218928642421714
Quarters > 3 > ratios > FCF
-364530671
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.717597849822289
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1710152000
Annuals > 0 > income Statement > cost Of Revenue
342796000
Annuals > 0 > income Statement > gross Profit
1367356000
Annuals > 0 > income Statement > operating Expenses
2738184000
Annuals > 0 > income Statement > operating Income
-1370828000
Annuals > 0 > income Statement > interest Expense
72379000
Annuals > 0 > income Statement > pretax Income
-1468362000
Annuals > 0 > income Statement > net Income
-1468362000
Annuals > 0 > income Statement > eps
-2.7317085215091836
Annuals > 0 > income Statement > dividends Per Share
-69826300
Annuals > 0 > income Statement > shares Outstanding
537525138
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1095374000
Annuals > 0 > income Statement > operating Margin
-80.15825493874229
Annuals > 0 > income Statement > total Other Income Expense Net
-97534000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
759530000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
623535000
Annuals > 0 > balance Sheet > inventories
659369000
Annuals > 0 > balance Sheet > total Current Assets
2289798000
Annuals > 0 > balance Sheet > property Plant Equipment
2978506000
Annuals > 0 > balance Sheet > total Assets
5498519000
Annuals > 0 > balance Sheet > payables
162250000
Annuals > 0 > balance Sheet > short Term Debt
1432539000
Annuals > 0 > balance Sheet > long Term Debt
1195878000
Annuals > 0 > balance Sheet > total Liabilities
3512318000
Annuals > 0 > balance Sheet > equity
1986201000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-1468362000
Annuals > 0 > cash Flow > depreciation
300609000
Annuals > 0 > cash Flow > change In Working Capital
-169491000
Annuals > 0 > cash Flow > cash From Operations
-1176596000
Annuals > 0 > cash Flow > capital Expenditures
265282000
Annuals > 0 > cash Flow > cash From Investing
-185907000
Annuals > 0 > cash Flow > cash From Financing
1392967000
Annuals > 0 > cash Flow > net Change In Cash
32978000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-2.7317085215091836
Annuals > 0 > ratios > PB
2.654878133572584
Annuals > 0 > ratios > ROE
-73.92816739091361
Annuals > 0 > ratios > ROA
-26.70468175157711
Annuals > 0 > ratios > FCF
-1441878000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.8431285640106845
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1076130000
Annuals > 1 > income Statement > cost Of Revenue
253136000
Annuals > 1 > income Statement > gross Profit
822994000
Annuals > 1 > income Statement > operating Expenses
2325340000
Annuals > 1 > income Statement > operating Income
-1502346000
Annuals > 1 > income Statement > interest Expense
23091000
Annuals > 1 > income Statement > pretax Income
-1511229000
Annuals > 1 > income Statement > net Income
-1511229000
Annuals > 1 > income Statement > eps
-2.7999996776134233
Annuals > 1 > income Statement > dividends Per Share
-15413850
Annuals > 1 > income Statement > shares Outstanding
539724705
Annuals > 1 > income Statement > income Tax Expense
32156118
Annuals > 1 > income Statement > EBITDA
-1247859000
Annuals > 1 > income Statement > operating Margin
-139.6063672604611
Annuals > 1 > income Statement > total Other Income Expense Net
-8883000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
709073000
Annuals > 1 > balance Sheet > short Term Investments
-120
Annuals > 1 > balance Sheet > receivables
449647000
Annuals > 1 > balance Sheet > inventories
741560000
Annuals > 1 > balance Sheet > total Current Assets
2228933000
Annuals > 1 > balance Sheet > property Plant Equipment
3042485000
Annuals > 1 > balance Sheet > total Assets
5528243000
Annuals > 1 > balance Sheet > payables
139331000
Annuals > 1 > balance Sheet > short Term Debt
344720000
Annuals > 1 > balance Sheet > long Term Debt
840588000
Annuals > 1 > balance Sheet > total Liabilities
2090974000
Annuals > 1 > balance Sheet > equity
3437269000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-1511229000
Annuals > 1 > cash Flow > depreciation
240279000
Annuals > 1 > cash Flow > change In Working Capital
-358324000
Annuals > 1 > cash Flow > cash From Operations
-1501829000
Annuals > 1 > cash Flow > capital Expenditures
852739000
Annuals > 1 > cash Flow > cash From Investing
-817650000
Annuals > 1 > cash Flow > cash From Financing
978307000
Annuals > 1 > cash Flow > net Change In Cash
-1342628000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.7999996776134233
Annuals > 1 > ratios > PB
1.5403796898206106
Annuals > 1 > ratios > ROE
-43.96597996839933
Annuals > 1 > ratios > ROA
-27.336515417285383
Annuals > 1 > ratios > FCF
-2354568000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.1879958741044296
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
767775000
Annuals > 2 > income Statement > cost Of Revenue
269939000
Annuals > 2 > income Statement > gross Profit
497836000
Annuals > 2 > income Statement > operating Expenses
1551915000
Annuals > 2 > income Statement > operating Income
-1054079000
Annuals > 2 > income Statement > interest Expense
6757000
Annuals > 2 > income Statement > pretax Income
-998830000
Annuals > 2 > income Statement > net Income
-998830000
Annuals > 2 > income Statement > eps
-1.8804884779447542
Annuals > 2 > income Statement > dividends Per Share
12498767
Annuals > 2 > income Statement > shares Outstanding
531154544
Annuals > 2 > income Statement > income Tax Expense
27479799
Annuals > 2 > income Statement > EBITDA
-805702000
Annuals > 2 > income Statement > operating Margin
-137.29009149816028
Annuals > 2 > income Statement > total Other Income Expense Net
55249000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2069180000
Annuals > 2 > balance Sheet > short Term Investments
69524622
Annuals > 2 > balance Sheet > receivables
299128000
Annuals > 2 > balance Sheet > inventories
522673000
Annuals > 2 > balance Sheet > total Current Assets
3212138000
Annuals > 2 > balance Sheet > property Plant Equipment
2667079000
Annuals > 2 > balance Sheet > total Assets
6021191000
Annuals > 2 > balance Sheet > payables
221692000
Annuals > 2 > balance Sheet > short Term Debt
60154000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
1040891000
Annuals > 2 > balance Sheet > equity
4980300000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-998830000
Annuals > 2 > cash Flow > depreciation
186371000
Annuals > 2 > cash Flow > change In Working Capital
-523640000
Annuals > 2 > cash Flow > cash From Operations
-1263689000
Annuals > 2 > cash Flow > capital Expenditures
757517000
Annuals > 2 > cash Flow > cash From Investing
-841557000
Annuals > 2 > cash Flow > cash From Financing
2426949000
Annuals > 2 > cash Flow > net Change In Cash
312359000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.8804884779447542
Annuals > 2 > ratios > PB
1.0462474302029998
Annuals > 2 > ratios > ROE
-20.055619139409274
Annuals > 2 > ratios > ROA
-16.58857857191376
Annuals > 2 > ratios > FCF
-2021206000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.6325499006870503
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1423902000
Annuals > 3 > income Statement > cost Of Revenue
67163000
Annuals > 3 > income Statement > gross Profit
1356739000
Annuals > 3 > income Statement > operating Expenses
1193901000
Annuals > 3 > income Statement > operating Income
162838000
Annuals > 3 > income Statement > interest Expense
5323000
Annuals > 3 > income Statement > pretax Income
276258000
Annuals > 3 > income Statement > net Income
276258000
Annuals > 3 > income Statement > eps
0.5667489930280116
Annuals > 3 > income Statement > dividends Per Share
70679779
Annuals > 3 > income Statement > shares Outstanding
487443301
Annuals > 3 > income Statement > income Tax Expense
120235442
Annuals > 3 > income Statement > EBITDA
402053000
Annuals > 3 > income Statement > operating Margin
11.436039839820438
Annuals > 3 > income Statement > total Other Income Expense Net
113420000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1756821000
Annuals > 3 > balance Sheet > short Term Investments
6142000
Annuals > 3 > balance Sheet > receivables
14511000
Annuals > 3 > balance Sheet > inventories
280314000
Annuals > 3 > balance Sheet > total Current Assets
2299953000
Annuals > 3 > balance Sheet > property Plant Equipment
1737428000
Annuals > 3 > balance Sheet > total Assets
4159209000
Annuals > 3 > balance Sheet > payables
159259000
Annuals > 3 > balance Sheet > short Term Debt
52454000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
712787000
Annuals > 3 > balance Sheet > equity
3446422000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
276258000
Annuals > 3 > cash Flow > depreciation
120472000
Annuals > 3 > cash Flow > change In Working Capital
-168160000
Annuals > 3 > cash Flow > cash From Operations
263631000
Annuals > 3 > cash Flow > capital Expenditures
617340000
Annuals > 3 > cash Flow > cash From Investing
-637947000
Annuals > 3 > cash Flow > cash From Financing
-626897000
Annuals > 3 > cash Flow > net Change In Cash
-1011700000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.5667489930280116
Annuals > 3 > ratios > PB
1.3874733804536996
Annuals > 3 > ratios > ROE
8.015791449799242
Annuals > 3 > ratios > ROA
6.64208026093423
Annuals > 3 > ratios > FCF
-353709000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
-0.24840824719678742
Annuals > 3 > health Score
63
Valuation > metrics > PE
-0.025263382871981304
Valuation > metrics > PB
16.921178004663016
Valuation > final Score
20
Valuation > verdict
464.0% Overvalued
Profitability > metrics > ROE
-4.3576574778465895
Profitability > metrics > ROA
-3.718130216630253
Profitability > metrics > Net Margin
-0.16378843802688026
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.5762568529876508
Risk > metrics > Interest Coverage
-6.1316337496906215
Risk > final Score
5
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.6417950025496317
Liquidity > metrics > Quick Ratio
1.2447514804944597
Liquidity > final Score
91
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
49.40369054419014
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-9
Prev Risks > 1
-20
Prev Risks > 2
-68
Prev Liquidities > 0
83
Prev Liquidities > 1
72
Prev Liquidities > 2
86
Updated At
2026-01-20T22:28:32.283Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-27
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
CNY
Earnings History > 1 > eps Actual
-0.0251
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-22
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0493
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-24
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CNY
Earnings History > 3 > eps Actual
-0.0651
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.1029
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-29
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
-0.0751
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-21
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
-0.1108
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-04-26
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
-0.0903
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2023-12-31
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
-0.1236
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
-0.0838
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
-0.1004
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
-0.0879
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
-0.081
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-27
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
-0.0538
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-30
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
-0.0567
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-27
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
-0.0929
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-16
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
0.2772
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-09-30
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
-0.0694
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
-0.0702
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0702
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
-0.0692
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0692
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
-0.0701
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0701
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
-0.0673
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0673
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
-0.0529
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0529
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CNY
Earnings History > 23 > eps Actual
-0.077
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.077
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CNY
Earnings History > 24 > eps Actual
-0.0343
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0343
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CNY
Earnings History > 25 > eps Actual
-0.0334
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0334
Earnings History > 25 > surprise Percent
-
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of various cancers. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARemeGen Co., Ltd. (OTCMKTS:REGMF) Short Interest Down 24.5% in December Defense World
Read more →Vor Bio stock gains bullish view at J.P. Morgan (VOR:NASDAQ) Seeking Alpha
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of RemeGen Co. Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0251
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.